AvePoint Investment Thesis slide image

AvePoint Investment Thesis

Summary Transaction Overview Transaction Description Transaction Structure AvePoint, Inc. ("AvePoint") and Apex Technology Acquisition Corp., "Apex" (NASDAQ: APXT) to combine to create a publicly listed company with a ~$2bn market capitalization (1) ■ Post-closing entity will be listed on NASDAQ under new ticker, AVPT, and maintain the AvePoint name The transaction is expected to close in the first quarter of 2021 Implied enterprise value of 9.0x 2021E revenue Existing AvePoint shareholders will be paid $257mm in cash consideration and issued 143.4mm shares in new AvePoint shares Transaction to be funded by a combination of approximately $352mm(2) Apex cash in trust and committed PIPE of $140 mm from institutional investors, led by Federated Kaufmann AvePoint is expected to have $252mm in cash on its balance sheet pro forma for the transaction Pro Forma Ownership 72% existing shareholders, 21% Apex public shareholders and founder shares and 7% PIPE investors Governance AvePoint co-founder and current CEO Tianyi ("TJ") Jiang will continue to serve as CEO AvePoint co-founder and current Executive Chairman Xunkai ("Kai") Gong will continue to serve as Executive Chairman ■ Jeff Epstein to join the Board of Directors and Brad Koenig to join as Board Observer ■ Expected Board of Directors: 7 members, of which majority are independents 1) Based on a $10.00 share price. 2) As of 30-Sep-2020. Note: Refer to transaction summary page for further detail. ▲ AvePoint 5
View entire presentation